Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Thomas Shook

Physician Assistant, Surgical Fresno, CA Physician Assistant

NPI 1770838856 CMS profile 10463460

2823 Fresno St, Fresno, CA 93650

Open in the dashboard

General payments

$2,426

33 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Thomas Shook of Fresno, CA is reported in the CMS Open Payments database as having received $2,426 across 33 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $76 4
2023 General $189 8
2022 General $2,141 20
2021 General $19 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Shook
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Thomas Shook were reported at $0. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Thomas Shook Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $19 $111 $36–$285 $132
2022 $2,141 $126 $44–$350 $149
2023 $189 $137 $47–$355 $160
2024 $76 $146 $49–$384 $164
2025 $0 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Intuitive Surgical, Inc. $1,901 7 payments
  2. Pfizer Inc. $88 5 payments
  3. Axonics Modulation Technologies, Inc. $69 1 payment
  4. Myovant Sciences Inc. $62 3 payments
  5. AbbVie, Inc. $56 3 payments
  6. PROCEPT BioRobotics Corporation $42 2 payments
  7. Antares Pharma, Inc. $38 2 payments
  8. Janssen Biotech, Inc. $32 2 payments
  9. Dendreon Pharmaceuticals LLC $27 1 payment
  10. Blue Earth Diagnostics Limited $21 1 payment
  11. Other $90 6 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Travel and Lodging $1,651 6 payments
  2. Food and Beverage $524 26 payments
  3. Education $250 1 payment
Products named General payments · program years 2021–2024
  1. Da Vinci Surgical System $1,651 6 payments
  2. DAVINCI XI $250 1 payment
  3. COMIRNATY $88 5 payments
  4. PAXLOVID $88 5 payments
  5. XTANDI $88 5 payments
  6. ORGOVYX Oncology $88 5 payments
  7. ORGOVYX Hormone Therapy $80 4 payments
  8. Axonics $69 1 payment
  9. XYOSTED $38 2 payments
  10. TLANDO $38 2 payments
  11. Other $298 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

546

Median for Physician Assistant: 241

Drug cost

$2,593

Median for Physician Assistant: $4,110

Branded share of claims

20.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Solifenacin Succinate Generic 58 $787
Cephalexin Generic 180 $479
Ketorolac Tromethamine Generic 20 $303
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 41 $272
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 60 $257
Ciprofloxacin Hcl Generic 82 $227
Tamsulosin Hcl Generic 43 $128
Tramadol Hcl Generic 49 $87
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 13 $53

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$7,746

Medicare's payments for the services billed

Medicare patients

54

Average age 72

Services billed

69

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 57%
Cancer 52%
Chronic kidney disease 48%
Arthritis 48%
Ischemic heart disease 43%
Heart failure 33%
Depression 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ERLEADA
  • Janssen Biotech, Inc. $32
$32 — —
POSLUMA
  • Blue Earth Diagnostics Limited $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

33 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record